Literature DB >> 7240194

Testicular microsomal cytochrome P-450 for C21 steroid side chain cleavage. Spectral and binding studies.

S Nakajin, P F Hall, M Onoda.   

Abstract

Kinetic and binding studies were performed with a purified microsomal cytochrome P-450 from neonatal pig testis, the C21 side chain cleavage system (17 alpha-hydroxylase/C17,20-lyase). Binding of substrates and inhibitors was measured by spectral methods and by equilibrium dialysis. Kinetic data revealed that pregnenolone inhibits lyase activity with 17 alpha-hydroxypregnenolone as substrate (Ki, 0.3 microM) and that progesterone inhibits lyase activity with 17 alpha-hydroxyprogesterone (Ki, 1.5 microM); inhibition is competitive in both cases. Binding and kinetic studies revealed that Km, Ks, and Kd (Michaelis constant and dissociation constants determined by spectral and dialysis methods, respectively) are all considerably lower for the delta 5 substrates than for the corresponding delta 4 compounds. Equilibrium dialysis shows that there is a single binding site for the substrates of both activities (hydroxylase and lyase). Spectral studies revealed a lag in the development of the spectral shift produced by the addition of steroids and gave results compatible with a single active site, although this spectral evidence is not conclusive by itself. It is concluded that (i) the powerful forward competitive inhibition by pregnenolone and progesterone may be important in regulating synthesis of androgens in vivo; (ii) the porcine enzyme uses delta 5 substrates in preference to delta 4 substrates, thereby accounting for extensive use of the delta 5 pathway by pig testis in vivo; (iii) the evidence presented suggests one active site for both hydroxylase and lyase activities.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240194

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  The syndrome of 17,20 lyase deficiency.

Authors:  Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

2.  Interaction of human CYP17 (P-450(17alpha), 17alpha-hydroxylase-17,20-lyase) with cytochrome b5: importance of the orientation of the hydrophobic domain of cytochrome b5.

Authors:  P Lee-Robichaud; M A Kaderbhai; N Kaderbhai; J N Wright; M Akhtar
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Specific accumulation of 17 alpha-hydroxyprogesterone in microsomal membranes during the process of cytochrome P-450(C-17)-catalysed androgen biosynthesis. A dynamic study of intermediate formation and turnover.

Authors:  N Kühn-Velten; M Lessmann; M E Förster; W Staib
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

4.  Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome.

Authors:  L H Zhang; H Rodriguez; S Ohno; W L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

5.  Deletion of the mouse P450c17 gene causes early embryonic lethality.

Authors:  Susanna R Bair; Synthia H Mellon
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

6.  Effects of new 17alpha-hydroxylase/C(17,20)-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo.

Authors:  D N Grigoryev; B J Long; I P Nnane; V C Njar; Y Liu; A M Brodie
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

7.  CYP17A1 deficient XY mice display susceptibility to atherosclerosis, altered lipidomic profile and atypical sex development.

Authors:  Jeanette Erdmann; Zouhair Aherrahrou; Redouane Aherrahrou; Alexandra E Kulle; Natalia Alenina; Ralf Werner; Simeon Vens-Cappell; Michael Bader; Heribert Schunkert
Journal:  Sci Rep       Date:  2020-05-29       Impact factor: 4.379

8.  Synthesis and Structure-Activity Relationships of Novel Non-Steroidal CYP17A1 Inhibitors as Potential Prostate Cancer Agents.

Authors:  Tomasz M Wróbel; Oksana Rogova; Katyayani Sharma; Maria Natalia Rojas Velazquez; Amit V Pandey; Flemming Steen Jørgensen; Frederic S Arendrup; Kasper L Andersen; Fredrik Björkling
Journal:  Biomolecules       Date:  2022-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.